Novartis: all 3,900 studies
Page 20 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Study of Accelerated Guideline-Directed Medical Therapy for Heart FailureCompletedNCT07217106
- Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United StatesCompletedNCT07214857
- Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of TreatmentCompletedNCT07188428
- Concept Elicitation and Patient Experience Mapping in SA-AKICompletedNCT07180238
- A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate CancerActive, not recruitingNCT07174063Phase 1
- A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in RussiaCompletedNCT07168694
- Fabhalta Capsules Specified Drug-use SurveyActive, not recruitingNCT07156149
- A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia PatientsCompletedNCT07151820
- A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in JapanCompletedNCT07150793
- A Study of Real-world Outcomes Among Patients Treated With RibociclibCompletedNCT07148505
- A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedNCT07103486
- Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary SyndromesActive, not recruitingNCT07102628Phase 3
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseActive, not recruitingNCT07094516Phase 2
- Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT07093801
- A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast CancerCompletedNCT07086196
- An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast CancerCompletedNCT07072013
- A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's DiseaseActive, not recruitingNCT07048197Phase 1/2
- A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Active, not recruitingNCT07047118Phase 2
- Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From IanalumabWithdrawnNCT07039422Phase 2
- A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia PatientsCompletedNCT07039383
- NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical PracticeTerminatedNCT07036718
- A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.CompletedNCT07032272Phase 1
- An Ascending Dose Study of PIT565 in Participants With Rheumatoid ArthritisActive, not recruitingNCT07029555Phase 1
- A Study About the Use of Omalizumab in the Treatment of Food Allergy and AnaphylaxisCompletedNCT07027163
- Patterns of Inclisiran Use in the Real World: An Analysis of US DatabasesCompletedNCT07023445
- Managed Access Programs for TQJ230, PelacarsenNo longer availableNCT07000695
- Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database StudyCompletedNCT06991894
- A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in GermanyActive, not recruitingNCT06991608
- An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Active, not recruitingNCT06991556Phase 2
- Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE StudyActive, not recruitingNCT06958315
- Inclisiran Effectiveness in China: a Pragmatic Randomized TrialActive, not recruitingNCT06941792Phase 4
- A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of LifeCompletedNCT06923124
- A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive SubjectsCompletedNCT06905327Phase 1
- Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH RegistryActive, not recruitingNCT06903234
- A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated PatientsCompletedNCT06897657
- An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPCActive, not recruitingNCT06894511Phase 2
- Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPCWithdrawnNCT06881823Phase 1/2
- Pelacarsen Roll-over Extension ProgramActive, not recruitingNCT06875973Phase 3
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of OfatumumabActive, not recruitingNCT06869785Phase 3
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPAActive, not recruitingNCT06868290Phase 2
- A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistaminesActive, not recruitingNCT06868212Phase 3
- A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive PatientsActive, not recruitingNCT06857955Phase 2
- A Canadian Study of Persistence on Ofatumumab Using Patient Support Program DataCompletedNCT06854341
- A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT06840392Phase 3
- Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVDActive, not recruitingNCT06813911Phase 3
- A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)Active, not recruitingNCT06799000Phase 3
- Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.CompletedNCT06785675
- Effectiveness of Ofatumumab in Real-world PracticeCompletedNCT06760624
- A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia GravisActive, not recruitingNCT06744920Phase 3
- Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical PracticeCompletedNCT06737419
- A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in BrazilTerminatedNCT06715254
- A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or AlpelisibCompletedNCT06705504
- Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia GravisActive, not recruitingNCT06704269Phase 1/2
- A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)CompletedNCT06699914
- Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of TherapyCompletedNCT06692803
- A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve HypertensionCompletedNCT06683768
- Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)Active, not recruitingNCT06675864Phase 1/2
- Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection FractionCompletedNCT06671314
- Effectiveness of Early Intervention in Transfusion Independent Aplastic Anemia: a Retrospective Medical Claims Database StudyCompletedNCT06669221
- Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous FormulationCompletedNCT06668324
- Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab EnvironmentCompletedNCT06666114
- Phase 2 Study of Rapcabtagene Autoleucel in MyositisActive, not recruitingNCT06665256Phase 2
- Real World Patient Characteristics and Treatment Patterns From Crizanlizumab Use: Preliminary Analysis From Select Sickle Cell CentersCompletedNCT06662825
- Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery RegistryCompletedNCT06662812
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT06655896Phase 2
- Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple SclerosisCompletedNCT06644638
- A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)Active, not recruitingNCT06643481Phase 2
- Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in SpainCompletedNCT06632730
- A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian FederationActive, not recruitingNCT06625333
- Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With ChemotherapyCompletedNCT06619704
- An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple SclerosisActive, not recruitingNCT06617793Phase 1/2
- Specified Drug-use Surveillance of Fabhalta CapsulesCompletedNCT06606314
- Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With HypertensionCompletedNCT06604897
- Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims DatabaseCompletedNCT06600009
- A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult PatientsCompletedNCT06595069
- A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple SclerosisCompletedNCT06588387
- A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)Active, not recruitingNCT06581198Phase 2
- Safety, Tolerability, and Pharmacokinetics of XXB750 in Healthy ParticipantsCompletedNCT06558097Phase 1
- Relapse-Free Survival With Adjuvant Dabrafenib/Trametinib Therapy in Patients With BRAF V600-mutated Stage III/IV MelanomaCompletedNCT06557291
- A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple SclerosisActive, not recruitingNCT06551519
- A Study to Evaluate the Impact of Long-term Digital Education vs Standard of Care on LDL-C Levels in Post Myocardial Infarction PatientsCompletedNCT06548555
- Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)Active, not recruitingNCT06547216Phase 2
- A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) StudyActive, not recruitingNCT06531499Phase 1
- Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 TherapiesCompletedNCT06526000
- A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.Active, not recruitingNCT06517758Phase 3
- Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian FederationActive, not recruitingNCT06517732
- Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With AsciminibCompletedNCT06516029
- A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial HypercholesterolemiaCompletedNCT06507852
- A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT06470048Phase 2
- Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL StudyCompletedNCT06463626
- Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host DiseaseActive, not recruitingNCT06462469Phase 4
- A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With OfatumumabCompletedNCT06460324
- Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying TherapiesCompletedNCT06459232
- Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple SclerosisActive, not recruitingNCT06444113Phase 4
- Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab InitiationActive, not recruitingNCT06444087
- A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.CompletedNCT06431763Phase 4
- Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic ArthritisWithdrawnNCT06431750
- Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I MutationCompletedNCT06427811Phase 4
- Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWithdrawnNCT06411639Phase 1
- Global Study of Del-desiran for the Treatment of DM1CompletedNCT06411288Phase 3